Patent · US Active

Pyrazolo pyrimidine derivatives and their use as MALT1 inhbitors

US10442808B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Carole Pissot Soldermann · Basel, CH
Jean Quancard · Huningue, FR
Achim Schlapbach · Bad Kötzting, DE
Oliver Simic · Basel, CH
Marina Tintelnot-Blomley · Maulburg, DE
Thomas Zoller · Andolsheim, FR

Key dates

Filing date	Oct 11, 2017
Grant date	Oct 15, 2019
Priority date	—
Expiry date	Oct 11, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention describes new pyrazolo-pyrimidine derivatives according to Formula (I) which are generally interacting with MALT1 proteolytic and/or autoproteolytic activity, and in particular which may inhibit said activity. The present invention further describes the synthesis of said new pyrazolo-pyrimidine derivatives, their use as a medicament, especially by interacting with MALT1 proteolytic and/or autoproteolytic activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.